TU‐E‐BRB‐09: Validation of Multi‐Focal Stereotactic Radiosurgery with Volumetric Modulated Arc Therapy with High‐Resolution 3D Dosimetry

Z. Wang, Joseph R Newton, M. Niebanck, T. Juang, J. Kirkpatrick, M. Oldham

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Volumetric modulated arc therapy (VMAT) enables stereotactic radiosurgery (SRS) treatment for multiple lesions with a single isocenter setup. Dosimetry verification is highly challenging however, and the purpose of this study is to validate this new treatment using novel 3D dosimetry techniques, with potential for dramatically more comprehensive verification than possible with conventional approaches. Methods: A cylindrical PRESAGE dosimeter was inserted into an RPC type head phantom for treatment validation. The phantom was immobilized with an SRS U‐frame system and a set of simulation CT images was acquired with a SRS localizer. A 5‐arc VMAT multi‐focal SRS plan was created to treat 5 intracranial lesions simultaneously. A set of cone‐beam CT (CBCT) images was then acquired to localize the isocenter, and the VMAT plan delivered to the combined phantom. The PRESAGE dosimeter was then removed and scanned by optical‐computed‐tomography (optical‐CT). The 3D PRESAGE dose measurement was reconstructed with 1 mm resolution. Another PRESAGE insert with a pre‐drilled ion chamber channel was placed in the phantom and an SRS ion chamber was mounted for an absolute dose measurement. The phantom was again localized with CBCT and the VMAT plan was delivered. The dose measured with the ion chamber was compared with calculated dose. Results: The mean planned and PRESAGE measured doses to target 1 were 12.1Gy and 12.2 Gy, 18.7 Gy and 18.5 Gy for target 2, 18.6 Gy and 18.4 Gy for target 3, 15.5 Gy and 15.4 Gy for target 4, 18.7 Gy and 19.0 Gy for target 5. The 3D gamma passing rate was 95.6% for 3% and 1mm. The ion chamber measured dose was within 1% of the planned dose. Conclusions: Our 3D PRESAGE dose measurement shows that multi‐focal VMAT is a valid technique for single isocenter SRS treatment of multiple lesions. This research is partially supported by NCI R01CA100835. This research is partially supported by NCI R01CA100835.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume39
Issue number6
DOIs
StatePublished - Jan 1 2012

Fingerprint

Intensity-Modulated Radiotherapy
Radiosurgery
Ions
Therapeutics
Ion Channels
Research
Head

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

TU‐E‐BRB‐09 : Validation of Multi‐Focal Stereotactic Radiosurgery with Volumetric Modulated Arc Therapy with High‐Resolution 3D Dosimetry. / Wang, Z.; Newton, Joseph R; Niebanck, M.; Juang, T.; Kirkpatrick, J.; Oldham, M.

In: Medical Physics, Vol. 39, No. 6, 01.01.2012.

Research output: Contribution to journalArticle

@article{14cf3182c4d346c2a69e8a8655be9c22,
title = "TU‐E‐BRB‐09: Validation of Multi‐Focal Stereotactic Radiosurgery with Volumetric Modulated Arc Therapy with High‐Resolution 3D Dosimetry",
abstract = "Purpose: Volumetric modulated arc therapy (VMAT) enables stereotactic radiosurgery (SRS) treatment for multiple lesions with a single isocenter setup. Dosimetry verification is highly challenging however, and the purpose of this study is to validate this new treatment using novel 3D dosimetry techniques, with potential for dramatically more comprehensive verification than possible with conventional approaches. Methods: A cylindrical PRESAGE dosimeter was inserted into an RPC type head phantom for treatment validation. The phantom was immobilized with an SRS U‐frame system and a set of simulation CT images was acquired with a SRS localizer. A 5‐arc VMAT multi‐focal SRS plan was created to treat 5 intracranial lesions simultaneously. A set of cone‐beam CT (CBCT) images was then acquired to localize the isocenter, and the VMAT plan delivered to the combined phantom. The PRESAGE dosimeter was then removed and scanned by optical‐computed‐tomography (optical‐CT). The 3D PRESAGE dose measurement was reconstructed with 1 mm resolution. Another PRESAGE insert with a pre‐drilled ion chamber channel was placed in the phantom and an SRS ion chamber was mounted for an absolute dose measurement. The phantom was again localized with CBCT and the VMAT plan was delivered. The dose measured with the ion chamber was compared with calculated dose. Results: The mean planned and PRESAGE measured doses to target 1 were 12.1Gy and 12.2 Gy, 18.7 Gy and 18.5 Gy for target 2, 18.6 Gy and 18.4 Gy for target 3, 15.5 Gy and 15.4 Gy for target 4, 18.7 Gy and 19.0 Gy for target 5. The 3D gamma passing rate was 95.6{\%} for 3{\%} and 1mm. The ion chamber measured dose was within 1{\%} of the planned dose. Conclusions: Our 3D PRESAGE dose measurement shows that multi‐focal VMAT is a valid technique for single isocenter SRS treatment of multiple lesions. This research is partially supported by NCI R01CA100835. This research is partially supported by NCI R01CA100835.",
author = "Z. Wang and Newton, {Joseph R} and M. Niebanck and T. Juang and J. Kirkpatrick and M. Oldham",
year = "2012",
month = "1",
day = "1",
doi = "10.1118/1.4735958",
language = "English (US)",
volume = "39",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - TU‐E‐BRB‐09

T2 - Validation of Multi‐Focal Stereotactic Radiosurgery with Volumetric Modulated Arc Therapy with High‐Resolution 3D Dosimetry

AU - Wang, Z.

AU - Newton, Joseph R

AU - Niebanck, M.

AU - Juang, T.

AU - Kirkpatrick, J.

AU - Oldham, M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Purpose: Volumetric modulated arc therapy (VMAT) enables stereotactic radiosurgery (SRS) treatment for multiple lesions with a single isocenter setup. Dosimetry verification is highly challenging however, and the purpose of this study is to validate this new treatment using novel 3D dosimetry techniques, with potential for dramatically more comprehensive verification than possible with conventional approaches. Methods: A cylindrical PRESAGE dosimeter was inserted into an RPC type head phantom for treatment validation. The phantom was immobilized with an SRS U‐frame system and a set of simulation CT images was acquired with a SRS localizer. A 5‐arc VMAT multi‐focal SRS plan was created to treat 5 intracranial lesions simultaneously. A set of cone‐beam CT (CBCT) images was then acquired to localize the isocenter, and the VMAT plan delivered to the combined phantom. The PRESAGE dosimeter was then removed and scanned by optical‐computed‐tomography (optical‐CT). The 3D PRESAGE dose measurement was reconstructed with 1 mm resolution. Another PRESAGE insert with a pre‐drilled ion chamber channel was placed in the phantom and an SRS ion chamber was mounted for an absolute dose measurement. The phantom was again localized with CBCT and the VMAT plan was delivered. The dose measured with the ion chamber was compared with calculated dose. Results: The mean planned and PRESAGE measured doses to target 1 were 12.1Gy and 12.2 Gy, 18.7 Gy and 18.5 Gy for target 2, 18.6 Gy and 18.4 Gy for target 3, 15.5 Gy and 15.4 Gy for target 4, 18.7 Gy and 19.0 Gy for target 5. The 3D gamma passing rate was 95.6% for 3% and 1mm. The ion chamber measured dose was within 1% of the planned dose. Conclusions: Our 3D PRESAGE dose measurement shows that multi‐focal VMAT is a valid technique for single isocenter SRS treatment of multiple lesions. This research is partially supported by NCI R01CA100835. This research is partially supported by NCI R01CA100835.

AB - Purpose: Volumetric modulated arc therapy (VMAT) enables stereotactic radiosurgery (SRS) treatment for multiple lesions with a single isocenter setup. Dosimetry verification is highly challenging however, and the purpose of this study is to validate this new treatment using novel 3D dosimetry techniques, with potential for dramatically more comprehensive verification than possible with conventional approaches. Methods: A cylindrical PRESAGE dosimeter was inserted into an RPC type head phantom for treatment validation. The phantom was immobilized with an SRS U‐frame system and a set of simulation CT images was acquired with a SRS localizer. A 5‐arc VMAT multi‐focal SRS plan was created to treat 5 intracranial lesions simultaneously. A set of cone‐beam CT (CBCT) images was then acquired to localize the isocenter, and the VMAT plan delivered to the combined phantom. The PRESAGE dosimeter was then removed and scanned by optical‐computed‐tomography (optical‐CT). The 3D PRESAGE dose measurement was reconstructed with 1 mm resolution. Another PRESAGE insert with a pre‐drilled ion chamber channel was placed in the phantom and an SRS ion chamber was mounted for an absolute dose measurement. The phantom was again localized with CBCT and the VMAT plan was delivered. The dose measured with the ion chamber was compared with calculated dose. Results: The mean planned and PRESAGE measured doses to target 1 were 12.1Gy and 12.2 Gy, 18.7 Gy and 18.5 Gy for target 2, 18.6 Gy and 18.4 Gy for target 3, 15.5 Gy and 15.4 Gy for target 4, 18.7 Gy and 19.0 Gy for target 5. The 3D gamma passing rate was 95.6% for 3% and 1mm. The ion chamber measured dose was within 1% of the planned dose. Conclusions: Our 3D PRESAGE dose measurement shows that multi‐focal VMAT is a valid technique for single isocenter SRS treatment of multiple lesions. This research is partially supported by NCI R01CA100835. This research is partially supported by NCI R01CA100835.

UR - http://www.scopus.com/inward/record.url?scp=84883394600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883394600&partnerID=8YFLogxK

U2 - 10.1118/1.4735958

DO - 10.1118/1.4735958

M3 - Article

AN - SCOPUS:84883394600

VL - 39

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -